Dr. Annet Nanvubya is a practicing Medical Doctor and researcher currently working with the UVRI-IAVI HIV Vaccine Program Ltd as the Clinical Trials Manager. She holds a PhD in Medical Sciences from the University of Antwerp in Belgium. As the Clinical Trials Manager, she is responsible for overseeing the conduct of clinical trials at the UVRI-IAVI HIV Vaccine Program Ltd. For the past 21 years, she participated in different epidemiological studies in high-risk fishing communities and phase I/II clinical trials which evaluated the safety and immunogenicity of various vaccine and drug candidates. She has also served as a co-Principal Investigator for two phase I/II HIV Vaccine trials, and she is currently part of the clinical team that is conducting the first phase III PrEP trial evaluating the safety of cabotegravir among high-risk women in fishing communities. She is currently a Principal Investigator of a Phase III COVID-19 trial that is evaluating the safety and efficacy of the Moderna vaccine in Africa. She is passionate about HIV/AIDS Biomedical research and improving sexual and reproductive health through conduct of related research.
Dr. Annet Nanvubya is a practicing Medical Doctor and researcher currently working with the UVRI-IAVI HIV Vaccine Program Ltd as the Clinical Trials Manager. She holds a PhD in Medical Sciences from the University of Antwerp in Belgium. As the Clinical Trials Manager, she is responsible for overseeing the conduct of clinical trials at the UVRI-IAVI HIV Vaccine Program Ltd. For the past 21 years, she participated in different epidemiological studies in high-risk fishing communities and phase I/II clinical trials which evaluated the safety and immunogenicity of various vaccine and drug candidates. She has also served as a co-Principal Investigator for two phase I/II HIV Vaccine trials, and she is currently part of the clinical team that is conducting the first phase III PrEP trial evaluating the safety of cabotegravir among high-risk women in fishing communities. She is currently a Principal Investigator of a Phase III COVID-19 trial that is evaluating the safety and efficacy of the Moderna vaccine in Africa. She is passionate about HIV/AIDS Biomedical research and improving sexual and reproductive health through conduct of related research.